drugset / Trial / NCT05311540

Zinc Supplementation In Very Low Birth Weight Infants-A Randomised Controlled Trial

NCT05311540

RandomizedSequentialDouble-blindPrevention

Summary

* Zinc (Zn) is a structural component of human body and is a crucial element for a wide variety of cascades that take place in almost all organ systems. * Due to many reasons, preterm infants are generally believed to be naturally in a negative Zn balance during the early periods of life. * Regulation of intestinal Zn absorption of preterms is unrelated to infant's Zn status. * There still is a lack of knowledge in the possible relation of Zn deficiency and development of NEC and/or feeding intolerance in preterm infants. * Even if Zn is studied as an adjunct treatment for neonates and young infants with sepsis and found to reduce treatment failure in these high risk population, data in preventing infectious diseases in preterm infants is still lacking.

Timeline

Start
2014-03-14
Primary completion
2015-03-02
Completion
2015-04-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Zinc Sulfate Unknown 9 mg Other